Kimberly-Clark plans to acquire Kenvue — the maker of Tylenol — in a cash-and-stock transaction valued at roughly $48.7 billion, forming a major powerhouse in the consumer health products industry.
Under the terms of the merger, shareholders of Kimberly-Clark — the company behind Huggies, Kleenex, and Cottonelle — will control about 54% of